EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Plasma E-Selectin Concentration as a Risk Marker for Atherosclerotic Vascular Damage in Patients with Early CAD

Monika Rac iD, Michal Rac, Andrzej Krzystolik, Krzysztof Safranow iD, Dariusz Chlubek iD, Violetta Dziedziejko iD

Biomolecules · 2024

DOI: 10.3390/biom15010022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Monika Rac und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Pomeranian Medical University, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland. Hauptthemen laut MEDLINE: E-Selectin, Coronary Artery Disease, Atherosclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammation markers in the blood may indicate a higher risk of unstable atherosclerosis. Selectins, a group of transmembrane glycoproteins, contribute to inflammation by helping certain blood cells bind to the endothelium.

Methods

The study included 100 patients with stable early-onset coronary artery disease (CAD), 75 men (aged 50–54) and 25 women (aged 55–64). Tests performed included biochemical analysis, ultrasound, and Doppler imaging of arteries and peripheral vessels. A biochemical control group of 50 cases without CAD (74% men, average age 48 ± 3.20 years) was also studied.

Results

Higher triglyceride levels were strongly linked to elevated plasma E-selectin levels. However, no significant relationship was found between plasma E-selectin levels and biochemical, clinical, radiographic, or echographic measures.

Conclusion

Plasma E-selectin levels are not a reliable marker for detecting atherosclerotic plaques or related problems in individuals with stable, well-managed CAD. While E-selectin levels can be measured in clinical labs using immunoassays, they cannot replace standard cardiological and vascular imaging tests for diagnosing cardiac or vascular conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

E-SelectinCoronary Artery DiseaseAtherosclerosisHumansMaleFemaleMiddle AgedBiomarkersRisk FactorsPlaque, Atherosclerotic

Stichwörter der Autor:innen

CAD risk markerE-selectinatherosclerosistriglycerides

Substanzen

E-SelectinBiomarkersSELE protein, human

Autor:innen und Institutionen

  • Department of Biochemistry, Pomeranian Medical University, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
  • Department of Diagnostic Imaging and Interventional Radiology, Pomeranian Medical University, Unii Lubelskiej 1, 71-252 Szczecin, Poland.
  • Department of Cardiology, County Hospital in Szczecin, Arkońska 4, 71-455 Szczecin, Poland.

ORCID-Profile: Monika Rac, Krzysztof Safranow, Dariusz Chlubek, Violetta Dziedziejko

Zitieren

APA

Rac, M., Rac, M., Krzystolik, A., Safranow, K., Chlubek, D., & Dziedziejko, V. (2024). Evaluation of Plasma E-Selectin Concentration as a Risk Marker for Atherosclerotic Vascular Damage in Patients with Early CAD. Biomolecules. https://doi.org/10.3390/biom15010022

Vancouver

Rac M, Rac M, Krzystolik A, Safranow K, Chlubek D, Dziedziejko V. Evaluation of Plasma E-Selectin Concentration as a Risk Marker for Atherosclerotic Vascular Damage in Patients with Early CAD. Biomolecules. 2024. doi:10.3390/biom15010022

BibTeX
@article{Rac2024,
  author = {Rac, Monika and Rac, Michal and Krzystolik, Andrzej and Safranow, Krzysztof and Chlubek, Dariusz and Dziedziejko, Violetta},
  title = {Evaluation of Plasma E-Selectin Concentration as a Risk Marker for Atherosclerotic Vascular Damage in Patients with Early CAD},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom15010022}
}
Kostenlos starten →